Utah Medical Products (UTMD) EBITDA Margin (2010 - 2026)
Utah Medical Products (UTMD) posted EBITDA Margin of 31.06% for Q2 2026, up 5.61% on a QoQ basis from 29.41% in Q1 2026, and down 105.0% year-over-year from 621.17% in Q2 2025.
Powered by 
Analysis
Utah Medical Products (UTMD) EBITDA Margin (2010 - 2026) Analysis & Trends
Utah Medical Products has reported EBITDA Margin for 17 years, with the latest figure at 31.06% in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 105.0% year-over-year to 31.06% in Q2 2026; TTM through Jun 2026 was 28.43%, a 408.0% decrease from a year earlier, with the FY2025 full-year figure at 29.6%, down 363.0% from the prior year.
- EBITDA Margin was 31.06% for Q2 2026 at Utah Medical Products, up from 29.41% in the prior quarter.
- The five-year high for EBITDA Margin was 39.68% in Q3 2022, with the low at 26.61% in Q3 2025.
- Average EBITDA Margin over 5 years is 33.13%, with a median of 32.76% recorded in 2025.
- The sharpest annual moves came in 2023 and 2024: EBITDA Margin sank 794 bps in 2023, then soared 167 bps in 2024.
- Over 5 years, EBITDA Margin stood at 37.35% in 2022, then fell by 14 bps to 31.98% in 2023, then increased by 0 bps to 32.0% in 2024, then declined by 16 bps to 26.99% in 2025, then increased by 15 bps to 31.06% in 2026.
- The last three EBITDA Margin figures came in at 31.06% (Q2 2026), 29.41% (Q1 2026), and 26.99% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.16 Bn | 175.56 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.68 Bn | 122.46 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.10 Bn | 108.28 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 104.81 Bn | 101.33 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.94 Bn | 45.69 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.07 Bn | 31.61 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.37 Bn | 30.42 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.77 Bn | 20.28 Bn | 684.20 Mn | 19.15% |
| 10 | Utah Medical Products | 220.01 Mn | 132.49 Mn | 4.76 Mn | 31.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.06% |
| Mar 31, 2026 | 29.41% |
| Dec 31, 2025 | 26.99% |
| Sep 30, 2025 | 26.61% |
| Jun 30, 2025 | 32.11% |
| Mar 31, 2025 | 32.47% |
| Dec 31, 2024 | 32.00% |
| Sep 30, 2024 | 33.41% |
| Jun 30, 2024 | 33.06% |
| Mar 31, 2024 | 34.24% |
| Dec 31, 2023 | 31.98% |
| Sep 30, 2023 | 31.74% |
| Jun 30, 2023 | 34.39% |
| Mar 31, 2023 | 35.46% |
| Dec 31, 2022 | 37.35% |
| Sep 30, 2022 | 39.68% |
| Jun 30, 2022 | 37.66% |
| Mar 31, 2022 | 36.70% |
| Dec 31, 2021 | 39.72% |
| Sep 30, 2021 | 40.55% |